Le Lézard
Classified in: Health

Steep Hill Offers Support to 2017 California Fire Victims and Offers Remediation Advice for Those Affected with Cannabis-Impacted Product


BERKELEY, Calif., Oct. 19, 2017 /PRNewswire/ -- Jmîchae?e Keller, President and CEO of Steep Hill, the global leader in cannabis science, testing and analytics, offered Steep Hill's support to the 2017 California fire victims and their families. "We were deeply saddened by the overwhelming devastation caused by the fires in Northern California and in other parts of the state.  We stand by to assist the cannabis community in answering the numerous questions we have received about the impact of smoke/ash-tainted product." 

Steep Hill's Chief Scientific Consultant Dr. Donald Land, Director of Cultivation Science Lydia Abernethy and Chief Research Officer Kymron DeCesare have prepared a Steep Hill report to respond questions on how to better understand best practices in handling smoke/ash-tainted product.  The link to the report is: http://steephill.com/blogs/39/Smoke-and-Ash-Adulteration-of-Cannabis-&-How-to-Remediate

In releasing the report, Dr. Land said, "Once cannabis is contaminated, it is hard to clean up.  In addition, clean up can be very expensive. Smoke taint destroys product. Smell and visual tests should be conducted immediately to check for tainted product. The presence of smoke and ash particulates can promote growth of unwanted and dangerous yeasts and molds.  We strongly caution cultivators from further adulterating cannabis with solvents and cleaners in an attempt to strip particulates. These products are detectable on final product and can be quantified by the lab."

Steep Hill's Chief Scientific Research and patient advocate Rev. Dr. Kymron DeCesare added, "It is important to remember that those with smoke allergies can experience hyper-sensitive responses when consuming smoke tainted cannabis. Patients must be extra careful to prevent exposure to tainted product."

"The use of fire retardant near cultivation sites or water sources can be risky for consumers and patients," added Lydia Abernethy. "Steep Hill's science team is standing by ready to assist growers in offering advice on how to best handle cannabis crops during this difficult time for our community."

For more information about Steep Hill visitwww.steephill.com

ABOUT STEEP HILL
Steep Hill Labs, Inc. is the world's leading cannabis science and technology company with significant footprints in lab testing, research and development, licensing, genetics and remote testing. No other company brings all of these sectors into one highly synergistic whole.  Steep Hill's foundation was built on testing and analyzing medical and recreational marijuana to ensure compliance with public safety standards.  In 2008, Steep Hill opened the first commercial cannabis lab in the United States and has been on the cutting edge since its inception. Steep Hill is expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt "best practices" in cannabis testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world.

Contact:
Cathie Bennett Warner
Cell: +1-415-420-1573
[email protected]

SOURCE Steep Hill Labs, Inc.


These press releases may also interest you

at 10:15
Sheppard, Mullin, Richter & Hampton LLP is pleased to announce that Kwan-Ho "Alex" Chung, Ph.D. has joined the firm's Intellectual Property practice group and Life Sciences industry team in Washington, D.C. Chung was most recently a partner at...

at 10:14
Public health researchers have a new, powerful tool from data and AI provider SAS to analyze the National Institutes of Health's All of Us Research Program's large and diverse data set. The NIH has added SAS Analytics Pro on SAS® Viya® to the All of...

at 10:10
HighField Biopharmaceuticals, a clinical stage immuno-oncology company using lipid-based therapeutics to treat cancer, announced today that two HighField abstracts have been accepted with one poster presentation at the American Society of Clinical...

at 10:10
Bicycle Therapeutics plc , a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the acceptance of two abstracts for poster presentation...

at 10:10
Dizal (SSE:688192), a biopharmaceutical company committed to developing groundbreaking new medicines for the treatment of cancer and immunological diseases, announced today that two abstracts featuring the latest data on sunvozertinib in non-small...

at 10:07
The American Association of Critical-Care Nurses (AACN) has published "AACN Standards for Appropriate Staffing in Adult Critical Care," the specialty's first, action-oriented staffing standards. Appropriate staffing has long been one of the "AACN...



News published on and distributed by: